BackThermo Fisher Scientific Overview

Thermo Fisher Scientific Accounts Payable

Latest accounts payable for TMO: $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average

Loading

Thermo Fisher Scientific Accounts Payable History

Loading

Thermo Fisher Scientific vs. peers: Accounts Payable Comparison

Loading

Thermo Fisher Scientific Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Thermo Fisher Scientific (TMO) FAQ

Thermo Fisher Scientific (TMO) currently reports a accounts payable of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Thermo Fisher Scientific's accounts payable history and peer comparisons.

Thermo Fisher Scientific's accounts payable changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Thermo Fisher Scientific reported $0 in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Thermo Fisher Scientific, and consider following TMO for alerts when major investors trade the stock.

Thermo Fisher Scientific is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TMO with unrelated industries.